<DOC>
	<DOC>NCT00734630</DOC>
	<brief_summary>This study will assess blood pressure reduction with nebivolol or placebo in patients taking lisinopril or losartan.</brief_summary>
	<brief_title>Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Male or female, ambulatory outpatients 1885 years old at screening Have a history of hypertension Qualifying laboratory results Severe hypertension, including chronic kidney disease Documented congestive heart failure Have clinically significant respiratory, liver, or heart disease History of stroke, heart attack, or heart surgery in the last 6 months Have a history of hypersensitivity to nebivolol or other beta blockers.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>nebivolol</keyword>
	<keyword>Bystolic â„¢</keyword>
	<keyword>lisinopril</keyword>
	<keyword>losartan</keyword>
	<keyword>Hypertension</keyword>
</DOC>